Cortisone
Adrenal Hyperplasia, Congenital
Federico II UniversitySmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 57/ 100
- Competitive Position
- 95/ 100
Competitive context
11 Active assets in the Adrenal Hyperplasia, Congenital cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Solu-Cortef University of Texas Southwestern Medical Center | Phase 4 | A |
Atumelnant Crinetics Pharmaceuticals Inc. | Phase 3 | BB |
FLUDROCORTISONE University of Texas Southwestern Medical Center | Phase 3 | BB |
DEXAMETHASONE Shanghai Jiao Tong University School of Medicine | Phase 4 | BB |
Crinecerfont Neurocrine Biosciences | Phase 3 | BB |
View all 21 →
Same molecule, other indications
Cortisone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →